Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding

被引:18
作者
Barmore, Austin J. [1 ]
Castex, Sally M. [1 ]
Gouletas, Brittany A. [1 ]
Griffith, Alex J. [1 ]
Metz, Slater W. [1 ]
Muelder, Nicolas G. [1 ]
Populin, Michael J. [1 ]
Sackett, David M. [1 ]
Schuster, Abigail M. [1 ]
Veldkamp, Christopher T. [1 ,2 ]
机构
[1] Univ Wisconsin, Dept Chem, 800 West Main St, Whitewater, WI 53190 USA
[2] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
关键词
Chemokines; Glycosaminoglycans; CCL19; CCL21; Heparin; Chimeric protein; LYMPH-NODE METASTASIS; RECEPTOR CCR7; GLYCOSAMINOGLYCAN BINDING; IN-VITRO; CELLS; EXPRESSION; MIGRATION; CANCER; DIMER; OLIGOMERIZATION;
D O I
10.1016/j.bbrc.2016.06.098
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokines direct the migration of cells during various immune processes and are involved in many disease states. For example, CCL19 and CCL21, through activation of the CCR7 receptor, recruit dendritic cells and nave T-cells to the secondary lymphoid organs aiding in balancing immune response and tolerance. However, CCL19 and CCL21 can also direct the metastasis of CCR7 expressing cancers. Chemokine binding to glycosaminoglycans, such as heparin, is as important to chemokine function as receptor activation. CCL21 is unique in that it contains an extended C-terminus not found in other chemokines like CCL19. Deletion of this extended C-terminus reduces CCL21's affinity for heparin and transferring the CCL21 C-terminus to CCL19 enhances heparin binding mainly through non-specific, electrostatic interactions. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:602 / 606
页数:5
相关论文
共 36 条
[1]   Chemokines in pathology and medicine [J].
Baggiolini, M .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (02) :91-104
[2]   Profiling heparin-chemokine interactions using synthetic tools [J].
de Paz, Lose L. ;
Moseman, E. Ashley ;
Noti, Christian ;
Polito, Laura ;
von Andrian, Ulrich H. ;
Seeberger, Peter H. .
ACS CHEMICAL BIOLOGY, 2007, 2 (11) :735-744
[3]  
Du P., 2016, GASTRIC CANC OFF J I
[4]  
Dyer D.P., 2016, J BIOL CHEM
[5]   Structure junction, and inhibition of chemokines [J].
Fernandez, EJ ;
Lolis, E .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :469-499
[6]   CCR7 and its ligands:: balancing immunity and tolerance [J].
Foerster, Reinhold ;
Davalos-Misslitz, Ana Clara ;
Rot, Antal .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (05) :362-371
[7]   Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer [J].
Fox, Jamie C. ;
Tyler, Robert C. ;
Peterson, Francis C. ;
Dyer, Douglas P. ;
Zhang, Fuming ;
Linhardt, Robert J. ;
Handel, Tracy M. ;
Volkman, Brian F. .
BIOCHEMISTRY, 2016, 55 (08) :1214-1225
[8]   Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation [J].
Fox, Jamie C. ;
Tyler, Robert C. ;
Guzzo, Christina ;
Tuinstra, Robbyn L. ;
Peterson, Francis C. ;
Lusso, Paolo ;
Volkman, Brian F. .
ACS CHEMICAL BIOLOGY, 2015, 10 (11) :2580-2588
[9]   Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7 [J].
Günther, K ;
Leier, J ;
Henning, G ;
Dimmler, A ;
Weissbach, R ;
Hohenberger, W ;
Förster, R .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (05) :726-733
[10]   INTERACTIONS OF CHEMOKINES WITH GLYCOSAMINOGLYCANS [J].
Hamel, Damon J. ;
Sielaff, India ;
Proudfoot, Amanda E. I. ;
Handel, Tracy M. .
METHODS IN ENZYMOLOGY, VOL 461: CHEMOKINES, PART B, 2009, 461 :71-102